v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating activities:      
Net loss $ (37,475) $ (103,194) $ (4,645)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 1,183 2,106 1,876
Amortization of identified intangible assets 3,541 4,473 4,189
Amortization of deferred loan origination costs 108 129 143
Amortization of deferred sales commissions 3,166 2,052 1,259
Non-cash lease expense 1,848 1,622 1,241
Stock-based compensation expense 12,242 3,905 556
Equity incentive bonus 0 32,626 0
Bad debt expense 535 195 636
Loss on disposition of asset 13 0 54
Deferred income tax benefit (3) (191) (127)
Loss (gain) on sale of marketable securities 42 (4) 0
Amortization of premium paid on marketable securities 426 0 0
Change in the fair value of the warrant liability (134) (1,242) 0
Changes in assets and liabilities      
Accounts receivable (1,854) (5,810) 1,934
Other assets 1,233 (3,293) (2,296)
Deferred sales commissions (4,256) (6,761) (2,465)
Accounts payable (505) 3,403 1,015
Accrued expenses (1,897) 2,199 (1,666)
Deferred revenue (107) 385 579
Operating lease liabilities (1,949) (1,664) (1,281)
Other long-term liabilities 24 7 68
Net cash provided by (used in) operating activities (23,819) (69,057) 1,070
Investing activities:      
Purchases of property and equipment (931) (1,582) (753)
Purchases of marketable securities (12,862) (50,797) 0
Proceeds from sale of marketable securities 3,451 1,250 0
Proceeds from maturities and principal paydowns of marketable securities 8,901 0 0
Acquisition of businesses, net of cash acquired 0 0 (20)
Proceeds from asset acquisition, net of cash paid 0 1,326 0
Net cash used in investing activities (1,441) (49,803) (773)
Financing activities:      
Proceeds from Merger and PIPE financing, net of cash paid 0 159,691 0
Repayments on loan payable (561) (1,816) (1,152)
Proceeds from drawdown on line of credit 0 0 4,672
Repayments of drawdown on line of credit 0 (4,672) 0
Debt issuance costs 0 (153) 0
Payments of contingent consideration liability 0 (5,969) 0
Repayments on finance lease obligations (26) (392) (752)
Payments of employees’ withholding taxes on net share settlement of share-based awards (775) 0 0
Proceeds from the structured payable arrangement 1,311 0 0
Principal payments under the structured payable arrangement (870) 0 0
Net cash provided by (used in) financing activities (921) 146,689 2,768
Effect of foreign currency translation (394) (78) (12)
Net increase (decrease) in cash, cash equivalents and restricted cash (26,575) 27,751 3,053
Cash, cash equivalents, and restricted cash beginning of period 47,317 19,566 16,513
Cash, cash equivalents, and restricted cash end of period 20,742 47,317 19,566
Supplemental disclosure of cash flow information:      
Interest paid 3,800 3,484 3,768
Income taxes paid 402 292 241
Supplemental schedule of noncash investing activities:      
Change in unrealized loss on marketable securities 1,235 177 0
Equipment and software acquired under finance lease obligations 0 0 74
Additional right-of-use assets 1,261 3,246 997
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents:      
Cash and cash equivalents 20,742 47,217 18,098
Restricted cash, current 0 100 1,368
Restricted cash, net of current 0 0 100
Total cash, cash equivalents and restricted cash $ 20,742 $ 47,317 $ 19,566

Source

PDF HTML
10-K Filing
ZIP XLS HTML
XBRL